Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study is the trial to demonstrate how our product is similar to remicade by comparing
the results of blood samples in active Ankylosing Spondylitis patients.